Showing 181 - 200 results of 25,042 for search '"CD"', query time: 0.09s Refine Results
  1. 181

    Epigenetic Control of Interferon-Gamma Expression in CD8 T Cells by Patrícia S. de Araújo-Souza, Steffi C. H. Hanschke, João P. B. Viola

    Published 2015-01-01
    “…Recently it has been recognized that epigenetic modification is an integral part of CD8 lymphocyte differentiation. This review will focus on the chromatin status of Ifng promoter in CD8 T cells and possible influences of epigenetic modifications in Ifng gene and conserved noncoding sequences (CNSs) in regulation of IFN-γ production by CD8 T lymphocytes.…”
    Get full text
    Article
  2. 182

    Bioavailability study of enantiopure (S)-Equol in CD(SD)IGS rats by Seethakallu Ramachandraiah AnandaKumar, Mukund Handral, Srinivas Seekallu

    Published 2025-01-01
    “…However, the pharmacokinetic study on the enantiopure (S)-Equol in male and female rats under graded doses remain untouched, and the study concentrates on the same. Male and female CD(SD)IGS rats were grouped into 8 groups and some groups were administered with 20, 60 and 160 mg/kg body weight, orally and other administered with intravenous bolus injection at 10 mg/kg body weight of (S)-Equol. …”
    Get full text
    Article
  3. 183

    Imaging of CD47 Expression in Xenograft and Allograft Tumor Models by Alexander Zheleznyak, Oluwatayo F. Ikotun, Julie Dimitry, William A. Frazier, Suzanne E. Lapi

    Published 2013-11-01
    “…CD47 functions as a marker of “self” by inhibiting phagocytosis of autologous cells. …”
    Get full text
    Article
  4. 184

    CD44: From diagnosis to therapy in the journey of oral cancer by Selvaraj Jayaraman, Vishnu Priya Veeraraghavan

    Published 2024-06-01
    “…. • CSCs in OSCC fuel chemo-radio-resistance, making their targeting crucial. • CD44, a CSC biomarker, drives cancer progression and resistance. • Elevated CD44 predicts poor outcomes in various cancers. • Studying CD44's role in OSCC is vital for validating its potential as a prognostic marker and therapeutic target.…”
    Get full text
    Article
  5. 185

    CD1-Restricted T Cells at the Crossroad of Innate and Adaptive Immunity by Catia S. Pereira, M. Fatima Macedo

    Published 2016-01-01
    “…Lipid-specific T cells comprise a group of T cells that recognize lipids bound to the MHC class I-like CD1 molecules. There are four isoforms of CD1 that are expressed at the surface of antigen presenting cells and therefore capable of presenting lipid antigens: CD1a, CD1b, CD1c, and CD1d. …”
    Get full text
    Article
  6. 186

    CD-ROM Nedir? Kütüphanecilik ve Bilgibilim Alanında Kullanımı by Münevver Dikeç

    Published 1987-12-01
    “…CD-ROMs (Compact Disk - Read Only Memory), vvhich have been fre* quently discussed in the literatüre, are introduced in this paper. …”
    Get full text
    Article
  7. 187
  8. 188
  9. 189
  10. 190
  11. 191
  12. 192
  13. 193
  14. 194
  15. 195

    Microglia modulate the cerebrovascular reactivity through ectonucleotidase CD39 by Zhongxiao Fu, Mallikarjunarao Ganesana, Philip Hwang, Xiao Tan, Melissa Marie Kinkaid, Yu-Yo Sun, Emily Bian, Aden Weybright, Hong-Ru Chen, Katia Sol-Church, Ukpong B. Eyo, Clare Pridans, Francisco J. Quintana, Simon C. Robson, Pankaj Kumar, B. Jill Venton, Anne Schaefer, Chia-Yi Kuan

    Published 2025-01-01
    “…Pharmacological inhibition or CX3CR1-CreER-mediated deletion of CD39 mimics the cerebral blood flow anomalies in microglia-deficient mice and reduces the upsurges of extracellular adenosine following whisker stimulation. …”
    Get full text
    Article
  16. 196

    哮喘患儿急性发作期CD4+ CD25+ 调节性 T细胞水平和体质量指数的关系

    Published 2010-01-01
    Subjects: “…CD4+ CD25+ 调节性T细胞…”
    Get full text
    Article
  17. 197

    De Novo Donor-Specific HLA Antibody Development and Peripheral CD4+CD25high Cells in Kidney Transplant Recipients: A Place for Interaction? by Josefina Alberu, Maria Inés Vargas-Rojas, Luis E. Morales-Buenrostro, Jose C. Crispin, Roxana Rodríguez-Romo, Norma O. Uribe-Uribe, Gabriel Carrasco, Diana Gómez-Martín, Jorge Alcocer-Varela

    Published 2012-01-01
    “…The aim of this study was to determine whether the abundance of regulatory T cells (Tregs) (CD4+CD25high) affects the de novo development of anti-HLA donor-specific antibodies (DSAs) in kidney transplant recipients (KTRs). …”
    Get full text
    Article
  18. 198

    TIM‐4 increases the proportion of CD4+CD25+FOXP3+ regulatory T cells in the pancreatic ductal adenocarcinoma microenvironment by inhibiting IL‐6 secretion by Ziyao Wang, Zerong Xie, Yu Mou, Ruiman Geng, Chen Chen, Nengwen Ke

    Published 2024-09-01
    “…Additionally, the mechanism may be through the CD8+ effector T cells (CD8+Tc). Conclusion TIM‐4 has the potential to be an immunotherapeutic target or to improve the efficacy of chemotherapy for PDAC.…”
    Get full text
    Article
  19. 199

    CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses by Alice Bergamini, Barbara Camisa, Attilio Bondanza, Fabio Ciceri, Chiara Bonini, Monica Casucci, Beatrice Greco, Camilla Bove, Silvia Arcangeli, Laura Falcone, Rita El Khoury, Anna De Lucia

    Published 2023-01-01
    “…Background To date, T cells redirected with CD19-specific chimeric antigen receptors (CAR) have gained impressive success in B-cell malignancies. …”
    Get full text
    Article
  20. 200

    Correlation of Interleukin-17-Producing Effector Memory T Cells and CD4+CD25+Foxp3 Regulatory T Cells with the Phosphate Levels in Chronic Hemodialysis Patients by Cheng-Lin Lang, Min-Hui Wang, Kuan-Yu Hung, Sung-Hao Hsu, Chih-Kang Chiang, Kuo-Cheng Lu

    Published 2014-01-01
    “…Interleukin-17-producing CD4+ effector memory T (Th17) cells and CD4+CD25+Foxp3 regulatory T (Treg) cells both play critical roles in immune activation and inflammation. …”
    Get full text
    Article